Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | lixisenatide | |
Synonyms |
AVE-010 Lyxumia AVE-0010 AVE 010 ZP10A peptide AVE0010 ZP-10 AQVE-10010 DES-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-l-lysyl-l-lysinamide ZP 10 Adlyxin AVE 0010 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C479460 |
|
altLabel |
AVE-010 Lyxumia AVE-0010 AVE 010 ZP10A peptide AVE0010 ZP-10 AQVE-10010 DES-38-proline-exendine-4 (Heloderma suspectum)-(1-39)-peptidylpenta-l-lysyl-l-lysinamide ZP 10 Adlyxin AVE 0010
|
|
cui |
C4307843 C4276110 C2973896 C3713829 C4307844 C2604519 C2973895 C1313707
|
|
HM |
D000067758 D010455
|
|
II |
D000067757
|
|
Inverse of RB |
74O62BB01U 0
|
|
LT |
TRD
|
|
Mapped to | ||
MDA |
20031208
|
|
MeSH Frequency |
255
|
|
MMR |
20230531
|
|
notation |
C479460
|
|
PI |
*CARRIER PROTEINS (2003-2010)
|
|
prefLabel |
lixisenatide
|
|
SC |
1
|
|
Scope Statement |
A synthetic GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist that binds GLP-1 receptor that is used to control blood sugar levels in patients with TYPE 2 DIABETES; amino acid sequence is H-HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSK KKKKK-NH2 (ZP10A).
|
|
SRC |
J Pharmacol Exp Ther 2003 Nov;307(2);490-6
|
|
TERMUI |
T000908879 T759901 T724131 T562103 T724133 T000908883 T000908881 T000908671 T000908880 T000908882 T000908884 T724132 T851434
|
|
TH |
NLM (2009) NLM (2008) FDA SRS (2017) USAN (19XX) INN (19XX) NLM (2003) NLM (2017) NLM (2014)
|
|
tui |
T116 T123 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping